TechCrunch @TechCrunch
Six-year-old Indian healthcare startup PharmEasy is acquiring a 66.1% stake in diagnostic giant Thyrocare, a 26-year-old publicly listed firm, for about $613 million. PharmEasy separately said it is in talks to raise $500 million at $4 billion valuation. https://t.co/MKUHz7QHPp — PolitiTweet.org